STABILE, ARMANDO
 Distribuzione geografica
Continente #
EU - Europa 3.443
AS - Asia 1.387
NA - Nord America 1.199
SA - Sud America 255
AF - Africa 32
OC - Oceania 2
Totale 6.318
Nazione #
IT - Italia 1.632
US - Stati Uniti d'America 1.140
RU - Federazione Russa 1.126
CN - Cina 434
SG - Singapore 378
BR - Brasile 192
HK - Hong Kong 153
NL - Olanda 146
SE - Svezia 135
VN - Vietnam 126
JP - Giappone 104
DE - Germania 77
FR - Francia 77
GB - Regno Unito 55
FI - Finlandia 48
BD - Bangladesh 47
IN - India 44
TR - Turchia 37
CA - Canada 30
AR - Argentina 27
PL - Polonia 25
ES - Italia 21
AT - Austria 18
MX - Messico 17
CZ - Repubblica Ceca 11
LT - Lituania 11
CO - Colombia 10
ZA - Sudafrica 10
BE - Belgio 8
CH - Svizzera 8
IQ - Iraq 8
AE - Emirati Arabi Uniti 7
IE - Irlanda 7
MA - Marocco 6
NO - Norvegia 6
UA - Ucraina 6
DK - Danimarca 5
DZ - Algeria 5
EC - Ecuador 5
PE - Perù 5
PH - Filippine 5
PK - Pakistan 5
SA - Arabia Saudita 5
VE - Venezuela 5
GR - Grecia 4
ID - Indonesia 4
MY - Malesia 4
NP - Nepal 4
PY - Paraguay 4
TN - Tunisia 4
UY - Uruguay 4
UZ - Uzbekistan 4
CL - Cile 3
IL - Israele 3
KE - Kenya 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EG - Egitto 2
HN - Honduras 2
IR - Iran 2
KR - Corea 2
PR - Porto Rico 2
RO - Romania 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AU - Australia 1
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
GE - Georgia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
KG - Kirghizistan 1
KH - Cambogia 1
KY - Cayman, isole 1
LB - Libano 1
LV - Lettonia 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PS - Palestinian Territory 1
SI - Slovenia 1
SN - Senegal 1
Totale 6.318
Città #
Milan 272
Singapore 220
Moscow 212
Ashburn 175
Hong Kong 147
San Jose 127
Rome 124
New York 120
Dallas 88
Shanghai 78
Beijing 72
Los Angeles 56
Turin 48
Hefei 43
Lauterbourg 40
Ho Chi Minh City 35
Verona 34
Florence 32
Bologna 31
Hanoi 30
Lawrence 29
Princeton 29
Tokyo 28
Boardman 24
Genoa 24
Munich 24
Palermo 24
São Paulo 24
Naples 22
Bari 21
Helsinki 21
Santa Clara 21
Warsaw 19
Chennai 18
Brooklyn 17
Frankfurt am Main 17
Orem 17
Turku 17
Chicago 16
Montreal 13
Bolzano 12
Brescia 12
Guangzhou 12
Manchester 12
Nuremberg 12
Trieste 12
Amsterdam 11
Azzano San Paolo 11
Buffalo 11
Catania 11
Council Bluffs 10
London 10
Stockholm 10
Ankara 9
Da Nang 9
Modena 9
Vienna 9
Atlanta 8
Bergamo 8
Denver 8
Paris 8
Phoenix 8
The Dalles 8
Bursa 7
Dublin 7
Falconara Marittima 7
Houston 7
Istanbul 7
Lamezia Terme 7
Padova 7
Pavia 7
Porto Alegre 7
Cesano Boscone 6
Columbus 6
Hayamiya 6
Johannesburg 6
Lappeenranta 6
Miami 6
Montepulciano 6
Parma 6
Toronto 6
Venice 6
Andria 5
Barnet 5
Brussels 5
Casablanca 5
Charleston 5
Dalian 5
Mexico City 5
Monza 5
Mumbai 5
Passo Fundo 5
Pisa 5
Poplar 5
Prato 5
Pune 5
Rio de Janeiro 5
Tianjin 5
Treviso 5
Valencia 5
Totale 2.852
Nome #
External Validation of the 2019 Briganti Nomogram for the Identification of Prostate Cancer Patients Who Should Be Considered for an Extended Pelvic Lymph Node Dissection 1.892
Impact of prostate imaging quality (PI-QUAL) score on the detection of clinically significant prostate cancer at biopsy 216
Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard 148
How to optimize follow-up in patients with a suspicious multiparametric MRI and a subsequent negative targeted prostate biopsy. Results from a large, single-institution series 142
Age and gleason score upgrading between prostate biopsy and radical prostatectomy: Is this still true in the multiparametric resonance imaging era? 127
Impact of Early Dorsal Venous Complex Ligation on Urinary Continence Recovery after Robot-assisted Radical Prostatectomy: Results from a Phase 3 Randomized Controlled Trial 125
Identification of the Optimal Candidates for Nodal Staging with Extended Pelvic Lymph Node Dissection Among Prostate Cancer Patients Who Underwent Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography. External Validation of the Memorial Sloan Kettering Cancer Center and Briganti Nomograms and Development of a Novel Tool 124
Positive Predictive Value of Prostate Imaging Reporting and Data System Version 2 for the Detection of Clinically Significant Prostate Cancer: A Systematic Review and Meta-analysis 123
Diagnostic Accuracy of Abbreviated Bi-Parametric MRI (a-bpMRI) for Prostate Cancer Detection and Screening: A Multi-Reader Study 121
Does previous prostate surgery affect multiparametric magnetic resonance imaging accuracy in detecting clinically significant prostate cancer? Results from a single institution series 120
Prostate-specific membrane antigen Radioguided Surgery to Detect Nodal Metastases in Primary Prostate Cancer Patients Undergoing Robot-assisted Radical Prostatectomy and Extended Pelvic Lymph Node Dissection: Results of a Planned Interim Analysis of a Prospective Phase 2 Study 119
Impact of prostate MRI central review over the diagnostic performance of MRI-targeted biopsy: should we routinely ask for an expert second opinion? 114
Optimizing prostate-targeted biopsy schemes in men with multiple mpMRI visible lesions: should we target all suspicious areas? Results of a two institution series 113
Defining the optimal target-to-background ratio to identify positive lymph nodes in prostate cancer patients undergoing robot-assisted [99mTc]Tc-PSMA radioguided surgery: updated results and ad interim analyses of a prospective phase II study 113
Variability of mpMRI diagnostic performance according to the upfront individual patient risk of having clinically significant prostate cancer 112
A Comprehensive Systematic Review and Meta-analysis of the Role of Prostate-specific Membrane Antigen Positron Emission Tomography for Prostate Cancer Diagnosis and Primary Staging before Definitive Treatment 107
Multiparametric magnetic resonance imaging of the prostate underestimates tumour volume of small visible lesions 106
Association Between Multiparametric Magnetic Resonance Imaging of the Prostate and Oncological Outcomes after Primary Treatment for Prostate Cancer: A Systematic Review and Meta-analysis 102
Defining Clinically Meaningful Positive Surgical Margins in Patients Undergoing Radical Prostatectomy for Localised Prostate Cancer 100
ASSOCIATION BETWEEN POLYMORPHISMS OF HOMOLOGOUS RECOMBINATION RAD51B AND DISEASE RECURRENCE IN A PROSPECTIVE COHORT OF PROSTATE CANCER PATIENTS UNDERGOING RADICAL PROSTATECTOMY 99
Assessing the need for systematic biopsies in addition to targeted biopsies according to the characteristics of the index lesion at mpMRI. Results from a large, multi-institutional database 99
External Validation of Nomograms for the Identification of Pelvic Nodal Dissection Candidates Among Prostate Cancer Patients with Negative Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography 97
Predictive value of preoperative neutrophil-to-lymphocyte ratio in localized prostate cancer: results from a surgical series at a high-volume institution 94
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD) 93
Interreader variability in prostate MRI reporting using Prostate Imaging Reporting and Data System version 2.1 92
Reducing the Risk of Postoperative Complications After Robot-assisted Radical Prostatectomy in Prostate Cancer Patients: Results of an Audit and Feedback Intervention Following the Implementation of Prospective Data Collection 92
There Is No Way to Avoid Systematic Prostate Biopsies in Addition to Multiparametric Magnetic Resonance Imaging Targeted Biopsies 91
Assessing the Clinical Value of Positive Multiparametric Magnetic Resonance Imaging in Young Men with a Suspicion of Prostate Cancer 90
Prognostic Implications of Multiparametric Magnetic Resonance Imaging and Concomitant Systematic Biopsy in Predicting Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer Patients Diagnosed with Magnetic Resonance Imaging-targeted Biopsy 89
Radioguided Surgery for Prostate Cancer 88
The quality of life of children and adolescents with X-linked agammaglobulinemia 80
Prediction of the Need for an Extended Lymphadenectomy at the Time of Radical Cystectomy in Patients with Bladder Cancer 79
Reply by Authors 79
Risk Stratification of Patients Candidate to Radical Prostatectomy Based on Clinical and Multiparametric Magnetic Resonance Imaging Parameters: Development and External Validation of Novel Risk Groups 78
Are Urologists Ready for Interpretation of Multiparametric MRI Findings? A Prospective Multicentric Evaluation 77
Association between Lesion Location and Oncologic Outcomes after Focal Therapy for Localized Prostate Cancer Using Either High Intensity Focused Ultrasound or Cryotherapy 77
Followup of Men with PI-RADS™ 4 or 5 Abnormality on Prostate Magnetic Resonance Imaging and Nonmalignant Pathological Findings on Initial Targeted Prostate Biopsy. Letter 72
The added value of artificial intelligence using Quantib Prostate for the detection of prostate cancer at multiparametric magnetic resonance imaging 69
Tailored use of PSA density according to multiparametric MRI index lesion location: results of a large, multi-institutional series 66
Utility of MRI perilesional biopsy in prostate cancer: impact of the Prostate Imaging-Reporting and Data System and biopsy history 63
Metastatic hormone‑sensitive prostate cancer: local treatment strategies 63
Survival after Radical Prostatectomy versus Radiation Therapy in High-Risk and Very High-Risk Prostate Cancer. Letter 61
RE: Retzius Sparing Prostatectomy Effect on Symptomatic Lymphocele Rates 61
Molecular biomarkers in the context of focal therapy for prostate cancer: recommendations of a Delphi Consensus from the Focal Therapy Society 60
Medium-term oncological outcomes in a large cohort of men treated with either focal or hemi-ablation using high-intensity focused ultrasonography for primary localized prostate cancer 55
Letter - Can micro-ultrasound be the new first-choice test for patients with a suspicion of prostate cancer? 51
Oncologic Surveillance for Variant Histology Bladder Cancer after Radical Cystectomy 50
The Role of Percentage of Prostate-specific Antigen Reduction After Focal Therapy Using High-intensity Focused Ultrasound for Primary Localised Prostate Cancer. Results from a Large Multi-institutional Series 45
Open Versus Robotic Cystectomy: A Propensity Score Matched Analysis Comparing Survival Outcomes 44
Global Variation in Magnetic Resonance Imaging Quality of the Prostate 42
Comparison of Single- and Multiport Robot-assisted Approaches in Prostate and Renal Surgery: A Systematic Review and Meta-analysis 10
null 1
null 1
Totale 6.432
Categoria #
all - tutte 24.406
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.406


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022114 0 12 4 8 8 7 15 14 5 10 17 14
2022/2023346 78 57 22 14 14 55 24 26 15 4 24 13
2023/2024686 12 16 37 47 50 131 43 77 11 80 78 104
2024/20251.550 186 70 119 73 105 145 207 185 165 87 91 117
2025/20263.723 252 189 155 458 355 121 305 339 988 252 170 139
Totale 6.432